Cancer Market Research Reports & Industry Analysis

This report contains 590 pages, 95 tables and presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

This report contains 565 pages, 85 tables and presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact ...

This report contains 620 pages, 85 tables and presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

This report contains 620 pages, 103 tables and presents a comprehensive analysis of the US cancer diagnostics market, including: Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the ...

... and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for ...

... market players and potential entrants; and suggests alternative business expansion strategies for suppliers. The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the ...

... as monoclonal antibodies, immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics ...

This 119-page report reviews current instrumentation technologies, and compares features of major automated and semiautomated analyzers used for cancer diagnostic testing. The report also presents strategic assessments of current and emerging suppliers of cancer ...

... Factors, Lymphokines, Immunohistochemical Stains and others. The report includes an overview of the clinical significance and market needs for both current and emerging cancer diagnostic tests, as well as extensive listings of companies, universities and research centers developing or ...

... new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the European cancer diagnostic testing market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for ...

... well as test volume and sales forecasts by country. The report also presents strategic analyses of leading current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative ...

Highlights Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years Examines trends in the U.S., Europe and Japan Reviews current and emerging tumor markers Analyzes applications of emerging diagnostic technologies Forecasts sales of major ...

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for over 40 tumor markers performed in French hospitals and commercial laboratories. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation ...

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation ...

... bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in German hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in Japanese hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in Spanish hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

Highlights Identifies and evaluates major business opportunities emerging in the tumor marker market during the next ten years Examines trends in the U.S., Europe and Japan Reviews current and emerging tumor markers Analyzes applications of emerging diagnostic technologies Forecasts sales of major ...

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for over 40 tumor markers performed in French hospitals and commercial laboratories. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation ...

... bladder, liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in German hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. Current instrumentation ...

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in Japanese hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

... , liver, ovarian, testicular, oral, skin and others. Ten-year test volume and sales forecasts over for 40 tumor marker performed in Spanish hospitals, commercial laboratories and physician offices. Placements and installed base of automated and semi-automated analyzers used for tumor marker testing. ...

Highlights Comprehensive 575-page analysis of the UK tumor marker testing market. Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

Highlights Comprehensive 620-page analysis of the US tumor marker testing market. Major issues pertaining to the US laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality statistics and ...

This report provides a worldwide overview of the cancer diagnostics market, including mortality statistics and scientific views on the etiology of major types of cancer, estimates of the number of laboratories performing cancer tests, as well as ten-year test volume and sales forecasts by country. Contains ...

Across the globe, oncology market, one of the fastest growing segments of pharmaceutical industry, has been expanding on back of rising cancer incidences, and hefty investment by private players. Acco...

... genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the ... identifies and evaluates major business opportunities emerging in the cancer diagnostics market during the next ten years; examines trends in the ...

This report presents a comprehensive analysis of the French cancer diagnostics market, including: Major issues pertaining to the French laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

This report presents a comprehensive analysis of the German cancer diagnostics market, including: Major issues pertaining to the German laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

This report presents a comprehensive analysis of the Italian cancer diagnostics market, including: Major issues pertaining to the Italian laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

This report presents a comprehensive analysis of the Japanese cancer diagnostics market, including: Major issues pertaining to the Japanese laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. ...

This report presents a comprehensive analysis of the Spanish cancer diagnostics market, including: Major issues pertaining to the Spanish laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

This report presents a comprehensive analysis of the UK cancer diagnostics market, including: Major issues pertaining to the UK laboratory practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next ten years. Mortality ...

The report identifies major opportunities emerging in the cancer diagnostics market during the next ten years; proposes “ideal” product models with tentative prices and operating characteristics; and suggests alternative business expansion strategies for suppliers. Contains 15 pages

Globally, cancer is one of the leading causes of death, and accounted for almost 13% of total deaths in 2008. The cases of lung and breast cancers are expected to grow rapidly in the coming years. In...

The report presents an overview of the clinical significance and market needs for major tumor markers, as well as listings of companies developing and marketing NAT technologies and products for cancer testing. Contains 45 pages

... Comprehensive 570-page analysis of the Italian tumor marker testing market. Major issues pertaining to the Italian laboratory practice, as well as key ... volume and sales forecasts for over 40 tumor marker performed in Italian hospitals and commercial laboratories. Placements and installed base of automated ...

This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages

... , immunoassays, DNA probes, biochips/microarrays, chromosome analysis, IT, flow cytometry, biosensors, and their potential applications for cancer diagnostic testing. Also included is a review of competing/complementing technologies, such as CT, MRI, NMR, PET and photonics spectroscopy. Contains 110 pages

... of about 2% of the overall prostate cancer therapeutics market. As far as drugs are concerned, Taxotere accounted for 23% of the total sales of prostate cancer drugs in 2010. Astrazeneca PLC ... to September 2011. Scope of the report The prostate cancer therapeutics market research report evaluates the global prostate cancer drugs market with respect to the current and ...

... report analyzes the worldwide markets for Cancer Therapies in US$ Million by the following Product Segments: Immunotherapy, Targeted Therapy, Hormonal Therapy, and Chemotherapy. ... 2017. A six-year historic analysis is also provided for these markets. The report profiles 152 companies including many key and ...

Based on a planned interim review of early data from ALTTO (Adjuvant lapatinib and/or Trastuzumab Treatment Optimization trial), a Phase III, four arm study of adjuvant ... hence has recommended patients assigned to Tykerb alone arm of the trial should discontinue. While DSMB has asked patients on the rest ...

... read our report released on 2nd September, 2011 on ONXX titled “Testing Time Ahead in the Hematological Cancer Space”.

... presents a comprehensive research report – Looking at the Cancer Therapy Market – which analyzes the global cancer market. Explaining the basics of cancer, to the treatments available and ...

... and much more. The 2009 edition of the report, "The Cancer Diagnostics Market: New Product Development and Business Strategies," is being updated by ... banking community in the U.S., five major European countries and Japan.The market projections are also based on questionnaire responses received from hospitals, ...

... CD20, VEGF and Her2, but also of many new and unique antibodies directed against novel targets which will have to show its ... cancer. In addition, the report lists company-specific R&D pipelines of anti-cancer antibodies. Competitor projects are listed in a tabular format providing information on: Drug Codes, ...